Systemic hypertension induced by hepatic overexpression of human preproendothelin-1 in rats

The Journal of Clinical Investigation
V NiranjanM Yanagisawa

Abstract

Endothelin-1 (ET-1) has been implicated in the regulation of vascular tone in various pathological conditions. To examine the effect of in vivo overexpression of the peptide in rats, we prepared recombinant adenovirus stocks encoding the human preproET-1 cDNA (Ad.ET-1) or Escherichia coli lacZ (Ad.betaGal), each driven by cytomegalovirus early promoter. Ad.ET-1 or Ad.betaGal was injected into the caudal vein of rats and the animals were studied under anesthesia 96 h later. Hepatic overexpression of the virus-derived human ET-1 mRNA was accompanied by a 13-fold elevation of liver ET-1 content in the Ad.ET-1 group. Circulating plasma ET-1 levels in the Ad.ET-1 group were sixfold higher than those in the Ad.betaGal group. Mean arterial blood pressure was increased by 28 mmHg in the Ad.ET-1 group as compared with the Ad.betaGal group. In the Ad.ET-1 group, intravenous infusion of the ET(A) receptor antagonist FR 139317 reduced the blood pressure to levels seen in the Ad.betaGal group, whereas the same antagonist did not significantly alter the blood pressure in the Ad.betaGal group. Intravenous infusion of the ET(B) receptor antagonist BQ-788 caused a small but significant increase in blood pressure in both groups. These findings d...Continue Reading

References

Jan 1, 1991·Journal of Cardiovascular Pharmacology·N SuzukiM Fujino
Dec 11, 1991·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·J WidimskyJ Dvorakova
Oct 13, 1991·The New England Journal of Medicine·A LermanJ C Burnett
Nov 21, 1991·The New England Journal of Medicine·J KollerM Herold
Feb 1, 1991·Annals of Internal Medicine·K YokokawaT Takeda
May 23, 1991·The New England Journal of Medicine·M IshibashiT Yamaji
Jul 1, 1991·Journal of the American College of Cardiology·D J StewartP Cernacek
Mar 30, 1990·Biochemical and Biophysical Research Communications·N SuzukiM Fujino
May 1, 1990·Hypertension·M ShichiriF Marumo
Nov 22, 1990·The New England Journal of Medicine·K KamoiT Yamaji
Jan 18, 1990·The New England Journal of Medicine·Y SaitoH Imura
Oct 19, 1989·The New England Journal of Medicine·K TomitaF Marumo
Oct 14, 1994·Biochemical and Biophysical Research Communications·S De LombaertR L Webb
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·E H OhlsteinJ S Frazee
Mar 30, 1994·Biochemical and Biophysical Research Communications·T FukurodaM Nishikibe
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·K IshikawaT Nagase
Nov 1, 1993·The American Review of Respiratory Disease·W DrumlO F Wagner
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J Herz, R D Gerard
Jan 1, 1993·Annual Review of Physiology·M S Simonson, M J Dunn
Nov 1, 1995·American Journal of Hypertension·J P GrattonP D'Orléans-Juste
Jan 1, 1995·Journal of Cardiovascular Pharmacology·H ShennibA Giaid
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·S KochanekC T Caskey

❮ Previous
Next ❯

Citations

Feb 19, 1999·Lancet·A Benigni, G Remuzzi
Sep 15, 1998·Kidney International. Supplement·S J Pinto-Sietsma, M Paul
Apr 12, 2000·Kidney International·A Benigni
Jan 26, 2005·Mayo Clinic Proceedings·Candelas Perez del VillarJ Carlos Romero
Feb 18, 2003·The Journal of Clinical Investigation·Scott P HeximerKendall J Blumer
Feb 4, 1999·Hypertension·Y TakedaH Mabuchi
Jul 13, 2005·Clinical Transplantation·Rafael L CauduroRoberto C Manfro
Jan 11, 2008·The Journal of Pharmacology and Experimental Therapeutics·Sabine TélémaqueJames D Marsh
May 22, 1998·Journal of Cardiovascular Pharmacology·S TélémaqueM Yanagisawa
Sep 28, 1999·Journal of Cardiovascular Pharmacology·F RuschitzkaT F Lüscher
Oct 5, 2006·Annals of Saudi Medicine·Enyioma ObinecheMichael P T Gillett
Jan 31, 1998·Cardiovascular Research·R D Gerard, D Collen
Apr 13, 1999·The American Journal of Physiology·T OhuchiM Kumada

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.